A case of Tietze’s syndrome visualized on PET/CT-FDG by Doudouh, Abderrahim et al.
88
Nuclear Medicine Review 2019, 22, 2: 88–89
DOI: 10.5603/NMR.2019.0021
Copyright © 2019 Via Medica
ISSN 1506–9680
Clinical 
vignette
www.journals.viamedica.pl/nuclear_medicine_review
Correspondence to: Yassir Benameur M.D., 
Department of Nuclear Medicine, Mohammed V Military Teaching Hospital, 
Mohammed V University of Rabat, BP 1018, Morocco; 
tel: +212 6 61 20 91 62, e-mail: benameur.yassir@gmail.com
A case of Tietze’s syndrome 
visualized on PET/CT-FDG
Abderrahim Doudouh, Yassir Benameur, Salah Nabih Oueriagli, Omar Ait Sahel, Abdelhamid Biyi
Mohammed V Military Teaching Hospital, Mohammed V University of Rabat., Po Box 6614. Rabat Institutes. 10101 Rabat, Morocco
[Received 4 III 2019; Accepted 27 VI 2019]
Abstract
We report an interesting image of a 49-year-old woman revealed with Tietze’s syndrome (TS) by 18F-FDG PET/CT. She presented 
with right upper sternum pain with a hard and fixed palpable mass. Chest radiograph and CT-Scanner revealed no abnormalities. 
PET/CT-FDG showed a hypermetabolic activity around right sternoclavicular joint, which was the correct symptomatic lesion. 
Hence, FDG PET/CT may be useful for diagnosing TS and to accurately detect the symptomatic lesion. 
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A 49-year-old woman suffered for one month from intermittent 
pain over the upper sternum, radiating occasionally towards the 
right arm. The pain was exacerbated by work. She noticed a tender 
swelling, the size of a plum, on her chest. There was no history of 
trauma to the area. 
Examination found a hard, fixed, and fusiform swelling meas-
uring approximately 3 x 2 cm, over the right sternoclavicular joint. 
There was no local inflammation or ecchymosis. Chest radiograph 
and CT scan revealed no abnormalities; the erythrocyte sedimenta-
tion rate was 7 mm/1hr, and the leukocyte count 3,500. 
Tietze’s syndrome (TS) was the first diagnosis admitted. 
To eliminate other possibilities, particularly malignant disease, 
PET/CT-FDG was performed and showed a hypermetabolic activity 
around right sternoclavicular joint with SUVmax = 3.4 visualized only 
under the cartilage and periarticular structures circumscribing the 
joint (Fig. 1). No other focal hypermetabolism was noted on bone 
material of chest, one focal hypermetabolism in right large intestine 
was noted, malignancy causes was eliminated by colonoscopy. 
Finally, TS was found and adequate treatment was established 
based on non-steroidal anti-inflammatory drugs.
TS was described for the first time in 1921 by the German 
surgeon Alexander Tietze [1]. It can be defined as benign, pain-
ful, non-suppurative, with localized swelling of the costosternal, 
costochondral, and/or sternoclavicular joints (Tietze’s area), in 
the absence of other causes which could be responsible for 
this disorder [1, 2]. Diagnosis of TS is not very easy because vari-
ability of characteristics of chest pain and nonspecific radiological 
and laboratory tests. It can be confused with many rheumatic 
and non-rheumatic diseases [3]. Thus, accurate diagnosis of TS 
is important, as it mimics malignant tumor and acute coronary 
syndrome [4]. In this situation, PET/CT-FDG is the elective method 
to explore total body with a high sensitivity and demonstrated hyper 
metabolic area to affirmed diagnosis of TS. 
In this syndrome, costochondritis is not suppurative and the 
histological examinations of the swellings showed non-specific find-
ings in the hyaline cartilage, consisting of an increased vascularity 
and degenerative changes with patchy loss of ground substance 
leading to a fibrillar appearance [5], explicating moderate hyper-
metabolism under the cartilage in PET/CT-FDG. 
FDG PET/CT is a hybrid imaging that has well-established use-
fulness for inflammatory disease and provides detailed anatomic 
information. Hence, FDG PET/CT may be useful for diagnosing TS 
and accurate detection of the symptomatic lesion [4].
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Figure 1. Coronal whole-body (left) and transaxial (right) fusion images showed 18F-FDG accumulation in the cartilage and periarticular structures 
of right sternoclavicular joint (SUVmax = 3.4) 
FDG — fluorodeoxyglucose, 18F — Fluor-18; PET — positron emission tomography; TS — Tietze’s syndrome; SUV — standardized uptake value
